PUCCI, FRANCESCA
 Distribuzione geografica
Continente #
AS - Asia 115
NA - Nord America 83
EU - Europa 65
SA - Sud America 31
AF - Africa 3
Totale 297
Nazione #
US - Stati Uniti d'America 78
SG - Singapore 63
BR - Brasile 28
IT - Italia 24
CN - Cina 16
HK - Hong Kong 16
VN - Vietnam 12
GB - Regno Unito 9
NL - Olanda 7
DE - Germania 4
AT - Austria 3
FR - Francia 3
MX - Messico 3
ZA - Sudafrica 3
CA - Canada 2
CH - Svizzera 2
FI - Finlandia 2
PL - Polonia 2
RU - Federazione Russa 2
SE - Svezia 2
UA - Ucraina 2
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
ID - Indonesia 1
IE - Irlanda 1
IQ - Iraq 1
JO - Giordania 1
JP - Giappone 1
KR - Corea 1
PK - Pakistan 1
PY - Paraguay 1
UZ - Uzbekistan 1
Totale 297
Città #
Singapore 37
Ashburn 20
Hong Kong 16
Santa Clara 13
Beijing 10
Arnhem 6
Hanoi 4
London 4
Bologna 3
Chicago 3
Elk Grove Village 3
Ho Chi Minh City 3
Salt Lake City 3
Brasília 2
Houston 2
Johannesburg 2
Los Angeles 2
Mexico City 2
Milwaukee 2
Naples 2
Pregassona 2
Sterling 2
Stockholm 2
Amman 1
Ann Arbor 1
Apucarana 1
Asunción 1
Barcarena 1
Betim 1
Bom Jesus da Lapa 1
Boston 1
Brooklyn 1
Buffalo 1
Cachoeiras de Macacu 1
Campinas 1
Cape Town 1
Cotia 1
Denver 1
Diadema 1
Dublin 1
Edmonton 1
Erbil 1
Espírito Santo 1
Fairfield 1
Feira de Santana 1
Formiga 1
Frankfurt am Main 1
Guangzhou 1
Guarujá 1
Guayaquil 1
Ha Long 1
Hefei 1
Helsinki 1
Hải Dương 1
Iztapalapa 1
Jakarta 1
Kita 1
Lappeenranta 1
Limeira 1
Manaus 1
Manchester 1
Maricá 1
Minsk 1
Montreal 1
Moscow 1
Multan 1
Munich 1
New York 1
Norwalk 1
Nuremberg 1
Orem 1
Parnaíba 1
Petrolina 1
Portsmouth 1
Poá 1
Princeton 1
Puerto Natales 1
Quatá 1
Raleigh 1
Rome 1
Rondonópolis 1
Santa Rosa 1
São Lourenço 1
Tampa 1
Tashkent 1
Teresina 1
Thành Phố Bà Rịa 1
Torres 1
Valparaíso de Goiás 1
Vienna 1
Warsaw 1
Wilmington 1
Totale 214
Nome #
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas 89
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial 84
SOCIAL HUB. Inclusione come motore di rigenerazione urbana nell’area dell’ex Foro Boario a Ferrara 76
Decoupling pulse tube vibrations from a dry dilution refrigerator at milli-Kelvin temperatures 32
NUCLEUS: cryogenic calorimeters to detect coherent nuclear scattering of reactor antineutrino 23
Particle background characterization and prediction for the NUCLEUS reactor CEνNS experiment 3
Totale 307
Categoria #
all - tutte 1.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 3 0 0 0
2021/20226 0 0 0 2 0 1 0 0 1 0 0 2
2022/20234 1 0 1 0 1 0 0 1 0 0 0 0
2023/20247 0 0 0 0 0 0 0 0 0 0 0 7
2024/202597 2 2 6 4 13 13 2 0 12 26 12 5
2025/2026190 28 13 25 48 66 10 0 0 0 0 0 0
Totale 307